Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections

Introduction: Today, orthopedic prostheses are being increasingly utilized in people with degenerative joint disease. In these patients, the aim is to increase the quality of life. However, associated infections, most commonly caused by staphylococci, sometimes result in a decrease in the quality of...

Full description

Bibliographic Details
Main Authors: Sevil SAPMAZ KARABAĞ, Vildan AVKAN OĞUZ, Nur YAPAR
Format: Article
Language:English
Published: Bilimsel Tip Yayinevi 2010-09-01
Series:Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Subjects:
Online Access:http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2010-15-3-118-122.pdf
_version_ 1797919392716029952
author Sevil SAPMAZ KARABAĞ
Vildan AVKAN OĞUZ
Nur YAPAR
author_facet Sevil SAPMAZ KARABAĞ
Vildan AVKAN OĞUZ
Nur YAPAR
author_sort Sevil SAPMAZ KARABAĞ
collection DOAJ
description Introduction: Today, orthopedic prostheses are being increasingly utilized in people with degenerative joint disease. In these patients, the aim is to increase the quality of life. However, associated infections, most commonly caused by staphylococci, sometimes result in a decrease in the quality of life. Therefore, we aimed to investigate the results of outpatient parenteral teicoplanin treatment. Patients and Methods: Fourteen patients between January 2006 and December 2007 retrospectively and 18 patients between January and December 2008 prospectively were included. Possible prosthesis infection was diagnosed by erythema, swelling, temperature increase in the operation area, and elevation of erythrocyte sedimentation rate and C-reactive protein levels. Teicoplanin (1 x 800 mg/day) was given to patients in whom methicillin-resistant staphylococci were isolated in at least two microbiological cultures taken during the prosthesis removal or in aspiration culture. Patients were followed up weekly. Results: Totally, 32 joint prosthesis patients infected with staphylococci were followed. Methicillin-resistant coagulase-negative staphylococci (75%) were the most common strain (24 patients), followed by methicillin-resistant Staphylococcus aureus (15.6%) (5 patients). Methicillin-susceptible coagulase-negative staphylococci were diagnosed in 2 (6.3%) patients and methicillin-susceptible S. aureus (3.1%) in 1 patient. The difference between mean C-reactive protein values before and after treatment was found to be significant (p= 0.000). Surgical debridement and teicoplanin treatment was successful in 87.5% of the cases; without surgical debridement, the treatment success rate was 71.9%. The cost of therapy for patients treated with outpatient teicoplanin therapy regimen was found lower than for the others treated with hospitalization. Conclusion: C-reactive protein remains the most valuable marker in the prosthesis infection diagnosis and follow-up. As we observed no side effects and the treatment success was high and effective, outpatient parenteral teicoplanin treatment can be an appropriate choice for joint prosthesis infections.
first_indexed 2024-04-10T13:44:48Z
format Article
id doaj.art-ab55b049dfa34bd88d702f12b6fcf42f
institution Directory Open Access Journal
issn 1300-932X
1300-932X
language English
last_indexed 2024-04-10T13:44:48Z
publishDate 2010-09-01
publisher Bilimsel Tip Yayinevi
record_format Article
series Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
spelling doaj.art-ab55b049dfa34bd88d702f12b6fcf42f2023-02-15T16:11:01ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X1300-932X2010-09-01153118122Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis InfectionsSevil SAPMAZ KARABAĞ0Vildan AVKAN OĞUZ1Nur YAPAR2Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Dokuz Eylul, Izmir, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Dokuz Eylul, Izmir, TurkeyDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, University of Dokuz Eylul, Izmir, TurkeyIntroduction: Today, orthopedic prostheses are being increasingly utilized in people with degenerative joint disease. In these patients, the aim is to increase the quality of life. However, associated infections, most commonly caused by staphylococci, sometimes result in a decrease in the quality of life. Therefore, we aimed to investigate the results of outpatient parenteral teicoplanin treatment. Patients and Methods: Fourteen patients between January 2006 and December 2007 retrospectively and 18 patients between January and December 2008 prospectively were included. Possible prosthesis infection was diagnosed by erythema, swelling, temperature increase in the operation area, and elevation of erythrocyte sedimentation rate and C-reactive protein levels. Teicoplanin (1 x 800 mg/day) was given to patients in whom methicillin-resistant staphylococci were isolated in at least two microbiological cultures taken during the prosthesis removal or in aspiration culture. Patients were followed up weekly. Results: Totally, 32 joint prosthesis patients infected with staphylococci were followed. Methicillin-resistant coagulase-negative staphylococci (75%) were the most common strain (24 patients), followed by methicillin-resistant Staphylococcus aureus (15.6%) (5 patients). Methicillin-susceptible coagulase-negative staphylococci were diagnosed in 2 (6.3%) patients and methicillin-susceptible S. aureus (3.1%) in 1 patient. The difference between mean C-reactive protein values before and after treatment was found to be significant (p= 0.000). Surgical debridement and teicoplanin treatment was successful in 87.5% of the cases; without surgical debridement, the treatment success rate was 71.9%. The cost of therapy for patients treated with outpatient teicoplanin therapy regimen was found lower than for the others treated with hospitalization. Conclusion: C-reactive protein remains the most valuable marker in the prosthesis infection diagnosis and follow-up. As we observed no side effects and the treatment success was high and effective, outpatient parenteral teicoplanin treatment can be an appropriate choice for joint prosthesis infections.http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2010-15-3-118-122.pdfOrthopedicsProsthesis-related infectionsTeicoplanin
spellingShingle Sevil SAPMAZ KARABAĞ
Vildan AVKAN OĞUZ
Nur YAPAR
Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi
Orthopedics
Prosthesis-related infections
Teicoplanin
title Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections
title_full Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections
title_fullStr Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections
title_full_unstemmed Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections
title_short Evaluation of Outpatient Parenteral Teicoplanin Treatment Results in Staphylococcal Orthopedic Prosthesis Infections
title_sort evaluation of outpatient parenteral teicoplanin treatment results in staphylococcal orthopedic prosthesis infections
topic Orthopedics
Prosthesis-related infections
Teicoplanin
url http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2010-15-3-118-122.pdf
work_keys_str_mv AT sevilsapmazkarabag evaluationofoutpatientparenteralteicoplanintreatmentresultsinstaphylococcalorthopedicprosthesisinfections
AT vildanavkanoguz evaluationofoutpatientparenteralteicoplanintreatmentresultsinstaphylococcalorthopedicprosthesisinfections
AT nuryapar evaluationofoutpatientparenteralteicoplanintreatmentresultsinstaphylococcalorthopedicprosthesisinfections